Aptamer Sciences Inc
KOSDAQ:291650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
KR |
|
J
|
J Sainsbury PLC
OTC:JSNSF
|
UK |
|
C
|
CNX Resources Corp
F:CGD
|
US |
|
U
|
UniCredit SpA
BMV:UCGN
|
IT |
|
C
|
CNX Resources Corp
SWB:CGD
|
US |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
H
|
HMM Co Ltd
KRX:011200
|
KR |
|
Castor Maritime Inc
NASDAQ:CTRM
|
CY |
|
Wells Fargo & Co
TSX:WFCS
|
US |
|
VentriPoint Diagnostics Ltd
F:5V7
|
CA |
|
CarePayment Technologies Inc
OTC:CPYT
|
US |
|
F
|
Fitness Champs Holdings Ltd
NASDAQ:FCHL
|
SG |
|
ON Semiconductor Corp
LSE:0KC4
|
US |
|
A
|
AK Alrosa PAO
MOEX:ALRS
|
RU |
|
China Communications Construction Co Ltd
F:CYY
|
CN |
|
SRT Marine Systems PLC
F:6S7
|
UK |
|
Medistim ASA
F:MD1
|
NO |
Bankruptcy Probability
Aptamer Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptamer Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
75.4B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptamer Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptamer Sciences Inc has total debt of 2B KRW. This includes both short-term (1.5B KRW) and long-term (419.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.